Back to top
Send SMS    Call Me Free
+918045801244

Cefuroxime Axetil Tablet Ip 250mg

Cefuroxime Axetil Tablet Ip 250mg

Product Details:

  • Grade A
  • Molecular Formula C20H22N4O10S
  • Purity 100%
  • CAS No LBT18-281
  • Application Other
  • Formulations Type External Use Drugs
  • Formulations Form Tablets
  • Supply Ability : Per Day
189.75 INR/Box
X

Price And Quantity

  • 189.75 INR/Box
  • 10 Box
  • 50.00 - 50.00 INR/Box

Product Specifications

  • LBT18-281
  • Other
  • AS DIRECTED BY PHYSICIAN
  • AS DIRECTED BY PHYSICIAN
  • External Use Drugs
  • A
  • Tablets
  • C20H22N4O10S
  • 100%
  • Dry Place
  • AS DIRECTED BY PHYSICIAN Kilogram(Kg)
  • Adult

Trade Information

  • AHMEDABAD
  • Cash in Advance (CID)
  • Per Day
  • Days
  • Yes
  • Within a certain price range free samples are available
  • 10*10
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India
  • YES

Product Description

Cefuroxime Axetil Tablet Ip 250mg 

*We have emerged as one of the leading manufacturers and suppliers of Cefuroxime Axetil Tablet Ip 250mg.

Brand Name : 
Safutral-250 Tablets
Mrp:-
 189.75
Packing Type : 
10*10 T
Composition:- Cefuroxime Axetil Tablet Ip 250mg.

  • Highly active against both Gram+ve & Gram-ve organisms
  • Highly active against beta lactamase producing strains of H.inflaunzae and N. gonorrhoeae, which are resistant to ampicillin and penicillin
  • Highly effective in the treatment of complicated UTI caused by resistant klebsiella
  • Most potent antibiotic against meningitis caused by Haemophilus influenzae, meningococci & pneumococci
  • Achieves superior Cure rates compared to co-amoxyclav in chronic bronchitis

 * Upper & Lower RTI

 * Urinary Tract Infections 

 * Bacterial Meningitis

 * Bone & Joint Infections

 * Gynecological Infections 

 * Skin & Soft Tissue Infections

 


ORION LIFE SCIENCE

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.